Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Titto Idicula

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 25, 2016
["Chronic ischemic changes" - a misleading term]Joan Crespi, Kjell Arne Kvistad, Titto Idicula
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 6, 2013
C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patientsHalvor Naess, Harald Nyland, Titto Idicula, et al.
BMC Neurology|November 16, 2023
Characteristics and predictors of stroke mimics in young patients in the norwegian tenecteplase stroke trial (NOR-TEST)Eskil Jacobsen, Nicola Logallo, Christopher Elnan Kvistad, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 10, 2010
High proportion of lacunar strokes at night: the Bergen stroke studyHalvor Naess, Titto Idicula, Jan Brogger, et al.
BMC Neurology|August 20, 2009
Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke StudyHalvor Naess, Jan C Brogger, Titto Idicula, et al.
BMC Neurology|June 18, 2026
Screening for undiagnosed obstructive sleep apnea in patients with acute stroke or TIAEinar Thokle Hovden, Wilhelm Eyde Kielland, Synne Bruun, et al.
The Lancet. Neurology|May 7, 2022
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trialChristopher Elnan Kvistad, Halvor Næss, Bernt H Helleberg, et al.
The Lancet. Neurology|August 7, 2017
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trialNicola Logallo, Vojtech Novotny, Jörg Assmus, et al.
European Stroke Journal|July 2, 2019
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and designBarbara Ratajczak-Tretel, Anna Tancin Lambert, Henriette Johansen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 25, 2016
["Chronic ischemic changes" - a misleading term]Joan Crespi, Kjell Arne Kvistad, Titto Idicula
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 6, 2013
C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patientsHalvor Naess, Harald Nyland, Titto Idicula, et al.
BMC Neurology|November 16, 2023
Characteristics and predictors of stroke mimics in young patients in the norwegian tenecteplase stroke trial (NOR-TEST)Eskil Jacobsen, Nicola Logallo, Christopher Elnan Kvistad, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 10, 2010
High proportion of lacunar strokes at night: the Bergen stroke studyHalvor Naess, Titto Idicula, Jan Brogger, et al.
BMC Neurology|August 20, 2009
Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke StudyHalvor Naess, Jan C Brogger, Titto Idicula, et al.
BMC Neurology|June 18, 2026
Screening for undiagnosed obstructive sleep apnea in patients with acute stroke or TIAEinar Thokle Hovden, Wilhelm Eyde Kielland, Synne Bruun, et al.
The Lancet. Neurology|May 7, 2022
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trialChristopher Elnan Kvistad, Halvor Næss, Bernt H Helleberg, et al.
The Lancet. Neurology|August 7, 2017
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trialNicola Logallo, Vojtech Novotny, Jörg Assmus, et al.
European Stroke Journal|July 2, 2019
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and designBarbara Ratajczak-Tretel, Anna Tancin Lambert, Henriette Johansen, et al.
Pageof 1